Hanna Lawnicka
Lodz, LD, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Assessing adverse event burden in chronic lymphocytic leukemia treatment regimens: what's best for patient quality of life?
Journal: Expert opinion on drug safety
Published: February 24, 2025
Growth hormone - releasing hormone in the immune system.
Journal: Reviews in endocrine & metabolic disorders
Published: September 27, 2024
Current Prospects for Adrenocortical Carcinoma Pharmacotherapy.
Journal: Recent patents on anti-cancer drug discovery
Published: December 12, 2021
IGF1R and MAPK15 Emerge as Potential Targets of Pentabromobenzylisothioureas in Lung Neuroendocrine Neoplasms.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 01, 2020
Elevated serum concentrations of IGF-1 and IGF-1R in patients with thyroid cancers.
Journal: Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
Published: November 14, 2018
Dysregulation in IGF-1R, FGFR4 and βKlotho signaling in patients with medullary thyroid cancer.
Journal: Neuro endocrinology letters
Published: July 18, 2018
Alteration in the serum concentrations of FGF19, FGFR4 and βKlotho in patients with thyroid cancer.
Journal: Cytokine
Published: January 11, 2018
Estimation of vitamin D status in patients with secondary and primary hypothyroidism of different etiology.
Journal: Neuro endocrinology letters
Published: March 08, 2017
Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer.
Journal: Disease markers
Published: November 16, 2016
Somatostatin Analogs and Tumor Localization Do Not Influence Vitamin D Concentration in Patients with Neuroendocrine Tumors.
Journal: Nutrition and cancer
Published: March 31, 2016
Decreased serum level of IL-7 in patients with active Graves' disease.
Journal: Cytokine
Published: January 20, 2015
Interferon alpha and rapamycin inhibit the growth of pheochromocytoma PC12 line in vitro.
Journal: Endokrynologia Polska
Published: November 04, 2013
Last Updated: 09/26/2026